SNP expands partnership with SAP
7.1.2025 09:23:08 CET | news aktuell GmbH | Press release
Long-standing partnership as strong foundation for extended collaboration
Expanded cooperation in global RISE with SAP transformation projects
Joint initiative to develop data migration and conversion scenarios for public cloud solutions
Heidelberg, Germany, January 6, 2025 – SNP SE, a leading software provider for digital transformation, automated data migration, and data management in SAP environments, is expanding its long-standing partnership with SAP, the global leader in enterprise applications and Business AI. SNP is a founding member of SAP’s Selective Data Transition Engagement community and a customer for RISE with SAP for many years. In addition, SNP is one of SAP’s leading services partners in the area of Cloud Application Lifecycle Management. Now, both companies are strengthening their partnership in the field of transformations to RISE with SAP and are exploring the potential collaboration in the space of data management in SAP S/4HANA Public Cloud.
Based on a successful track record with joint customers like BMW, Pfizer, E.ON or TE Connectivity, SNP is now intensifying its collaboration with SAP to accelerate the move of customers to RISE with SAP in a fast, compliant and efficient way with minimum risks and near-zero downtime. With SNP’s Bluefield methodology, companies can get the benefits of a transformative process redesign while retaining historical data aligned to a new business reality.
In addition, SNP is also expanding its collaboration with SAP in the Public Cloud space, leveraging the
strengths of both companies to develop data migration and conversion scenarios within SAP‘s public
cloud offerings for a global customer base.
Stefan Steinle, Executive Vice President, Global Head of Customer Support & Cloud Lifecycle Management at SAP, says: "Data migration is a critical element in all cloud transformations, and our partners play a key role here. With its Bluefield methodology, SNP is a long-standing partner with a strong track record in SAP S/4HANA Cloud and RISE with SAP projects. We are now strengthening the collaboration with a clear focus on customer success and aligning on future migration solutions for the Public Cloud. We are looking forward to expanding our partnership with SNP to drive the adoption of Cloud and Business AI.”
Jens Amail, CEO at SNP, adds: "We are very thankful for the trust our clients and partners put in us. SAP and SNP share objectives and successfully collaborate in many customer transformation projects
globally. With our new software platform SNP Kyano, we are now also migrating data from 3rd-party sources to SAP, and we are investing in the next generation of Bluefield for the Public Cloud. So now is the perfect time to double down on our collaboration with SAP, focusing on winning together with our customers and our joint ecosystem.”
About SNP
SNP (ticker: SHF.DE) is the global technology platform leader and trusted partner for companies seeking unparalleled data-enabled transformation capabilities and business agility. SNP’s Kyano platform integrates all necessary capabilities and partner offerings to provide a comprehensive software-based experience in data migration and management. Combined with the BLUEFIELD approach, Kyano sets a comprehensive industry standard for restructuring and modernizing SAP-centric IT landscapes faster and more securely while harnessing data-driven innovations.
The company works around the world with more than 3,000 customers of all sizes and in all industries, including 20 of the DAX 40 and more than 100 of the Fortune 500. The SNP Group has more than 1,500 employees worldwide at over 35 locations in 20 countries. The company is headquartered in Heidelberg, Germany, and generated revenues of EUR 203.4 million in the 2023 fiscal year.
More information is available at www.snpgroup.com
SAP and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP. Please see https://www.sap.com/copyright for additional trademark information and notices. All other product and service names mentioned are the trademarks of their respective companies.
Press Contact at SNP
Paola Krauss
Mobile: +49 172 72 95 928
Email: paola.krauss@snpgroup.com
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Grünenthal strengthens its Genetic Medicine Capabilities and joins the Cluster for Nucleic Acid Therapeutics Munich16.7.2026 10:42:31 CEST | Press release
Aachen, Germany, 16 July 2026 – Grünenthal announced today that the company has joined the Cluster for Nucleic Acid Therapeutics Munich (CNATM), a Munich-centred innovation network that brings together leading universities, research institutions, biotech companies and industry partners to accelerate next-generation nucleic acid therapeutics into innovative treatments that can make a meaningful difference for patients
They’re really going for it: emporia launches the first 5G smartphone with a screen warranty15.7.2026 08:40:22 CEST | Press release
Better safe than sorry: the emporiaSMART.8 with Smartcover and rubber protectors
FEV collaborates with Microsoft on efficient AI model approach for in car applications built on NVIDIA9.7.2026 11:05:00 CEST | Press release
Aachen – FEV is collaborating with Microsoft to integrate powerful, in-vehicle Generative AI capabilities built on NVIDIA GPU-accelerated compute and AI model microservices. The cooperation aims to enable multimodal voice, text, and gesture interactions directly in the vehicle – independent of a permanent Internet connection.
Acrobat Studio og Acrobat KI-assistent: den nye generasjonen KI-støttet produktivitet – nå også på norsk8.7.2026 15:08:48 CEST | Press release
SAN JOSE, Calif. - 8. juli 2026 - Adobe utvider tilgjengeligheten til Acrobat Studio og Acrobat KI-assistenten i Norge. Nå er de KI-støttede funksjonene for produktivitet og kreavtivitet også tilgjengelige på norsk, og kan dermed brukes av brukere på lokalt språk. Acrobat Studio kombinerer Adobe Acrobat Pro, Adobe Express Premium og smarte KI-assistenter. Acrobat KI-assistent er også tilgjengelig som et separat tillegg for alle Adobe Acrobat-produkter (Acrobat Reader, Acrobat Standard og Acrobat Pro) – et fleksibelt alternativ for alle som ønsker å bruke KI-støttede funksjoner kun når de arbeider med dokumenter. Begge disse tilbudene gjør det mulig for brukere å raskere samle inn informasjon i PDF-er og Office-dokumenter, opprette innhold og effektivisere arbeidsflyten. Acrobat Studio og Acrobat KI-assistenten markerer et viktig trinn i utviklingen av PDF-filen, som har blitt standarden for viktige dokumenter siden den ble lansert av Adobe i 1993. Acrobat utvikler seg fra et ledende pr
Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy8.7.2026 10:37:04 CEST | Press release
Aachen, 08 July 2026 – Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD).
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom